Treatment

IRINOTECAN, FLUOROURACIL, CALCIUM FOLINATE, OXALIPLATIN clinical trials

1 indexed studies · 0 currently recruiting

Ongoing, recruitingTherapeutic use (Phase IV)
SURVIVAL ANALYSIS AFTER NEOADJUVANT TREATMENT IN RESECTABLE PANCREATIC CANCER WITH RISK FACTORS
This study looks at how long people with a certain type of pancreatic cancer live after receiving treatment. It specifically focuses on real-world experiences with common chemotherapy drugs before surgery.
For: Resectable pancreatic adenocarcinoma with risk factors
Spain